Bo Fu

4.2k citations
125 papers · 3.3k indexed · h-index 34

Impact in

  • Nephrology top 1%
    • Renal Diseases and Glomerulopathies
    • Chronic Kidney Disease and Diabetes
  • Aging top 5%

Papers in

Bo Fu

121 papers receiving 3.3k citations

Peers

Bo Fu
Comparison fields: 5 of 149
  • Nephrology 515
  • Aging 85
  • Geriatrics and Gerontology 133
  • Genetics 350
  • Cancer Research 294
Replace Yanrong Lu with:
Yanrong Lu China
Francesc Ventura Spain
Huimei Chen China
Mitchell D. Knutson United States
Huali Zhang China
Beom‐Jun Kim South Korea
Bo Chen China
Yali Zhou China
Lei Cao China
Jiao Meng China
Bo Fu relative to Yanrong Lu China Yanrong Lu's profile →
Citations per field
00.5×1.5×2.1×
Yanrong Lu · 1×
Citations per year

Countries citing papers authored by Bo Fu

Since Specialization
Citations

This map shows the geographic impact of Bo Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Fu more than expected).

Fields of papers citing papers by Bo Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Fu. The network helps show where Bo Fu may publish in the future.

Co-authors

The 25 scholars most cited alongside Bo Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bo Fu Line = papers co-authored together Bo Fu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2019142
2 2014132
3 2017102
4 201399
5 201299
6 201296
7 201390
8 202082
9 201571
10 201370
11 201769
12 201368
13 201161
14 201360
15 201459
16 202155
17 202053
18 201651
19 201247
20 200847

About Bo Fu

Bo Fu is a scholar working on Nephrology, Geriatrics and Gerontology, Aging, Genetics and Cancer Research, having authored 125 papers that have together received 3.3k indexed citations. Recurring topics across this work include Renal and related cancers (12 papers), Autophagy in Disease and Therapy (10 papers), Renal Diseases and Glomerulopathies (9 papers), Telomeres, Telomerase, and Senescence (8 papers), Mesenchymal stem cell research (7 papers), Metal-Organic Frameworks: Synthesis and Applications (7 papers), Advanced Photocatalysis Techniques (7 papers) and Chronic Kidney Disease and Diabetes (6 papers). The work is most often cited by research in Nephrology (515 citations), Aging (85 citations), Geriatrics and Gerontology (133 citations), Genetics (350 citations) and Cancer Research (294 citations). Bo Fu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiangmei Chen, Guangyan Cai, Quan Hong, Shaoyuan Cui, Zhe Feng, Xueyuan Bai, Xuefeng Sun, Li Zhang, Diangeng Li and Congjuan Luo. Their work appears in journals such as ACS Omega, Kidney International, Stem Cell Research & Therapy, International Journal of Biological Macromolecules and The Journals of Gerontology Series A.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026